BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25260651)

  • 1. Effect of drug transporter pharmacogenetics on cholestasis.
    Dietrich CG; Geier A
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
    Stieger B; Geier A
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of hepatocellular transporters.
    Pauli-Magnus C; Meier PJ
    Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary transporters and drug-induced cholestasis.
    Pauli-Magnus C; Meier PJ
    Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of cholestasis.
    Hirschfield GM
    Clin Liver Dis; 2013 May; 17(2):147-59. PubMed ID: 23540495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
    Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
    Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions.
    Bohan A; Boyer JL
    Semin Liver Dis; 2002; 22(2):123-36. PubMed ID: 12016544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cholestasis.
    Zollner G; Trauner M
    Clin Liver Dis; 2008 Feb; 12(1):1-26, vii. PubMed ID: 18242495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis and cholestatic syndromes.
    Pratt DS
    Curr Opin Gastroenterol; 2005 May; 21(3):270-4. PubMed ID: 15818146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug- and chemical-induced cholestasis.
    Mohi-ud-din R; Lewis JH
    Clin Liver Dis; 2004 Feb; 8(1):95-132, vii. PubMed ID: 15062196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.
    Fickert P; Fuchsbichler A; Marschall HU; Wagner M; Zollner G; Krause R; Zatloukal K; Jaeschke H; Denk H; Trauner M
    Am J Pathol; 2006 Feb; 168(2):410-22. PubMed ID: 16436656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
    Gartung C; Matern S
    Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical causes of cholestasis.
    Nguyen KD; Sundaram V; Ayoub WS
    World J Gastroenterol; 2014 Jul; 20(28):9418-26. PubMed ID: 25071336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.